Status:
UNKNOWN
QLB and Laparoscopic Nephrectomy, Postoperative Pain and Recovery
Lead Sponsor:
Tampere University Hospital
Conditions:
Postoperative Pain
Chronic Pain Post-Proceduraal
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
There are ca 900 new cases of kidney cancer in Finland/year. The curative therapy for kidney cancer is partial or total nephrectomy depending on the localization and the size of tumor. Main of these o...
Eligibility Criteria
Inclusion
- patients with renal cancer coming to the laparoscopic radical nephrectomy
Exclusion
- age under 18y or over 85y
- diabetes type 1 with complications
- no co-operation or inadequate finnish language skills
- persistent pain for other reason
- severe hepatic insufficiency or paracetamol (acetaminophen) is contraindicated for other reason
- any type of steroid in regular use
- oxycodone contraindicated
- medications changing notably paracetamol (acetaminophen) and/or ropivacaine metabolism in regular use
Key Trial Info
Start Date :
December 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03339284
Start Date
December 4 2017
End Date
June 30 2023
Last Update
December 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland